Autoimmune Disease Therapeutics Market - Global Outlook and Forecast 2022-2028

Autoimmune Disease Therapeutics Market - Global Outlook and Forecast 2022-2028

Report Code: KNJ1156217 | No. of Pages: 65 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Jan-2022
This report contains market size and forecasts of Autoimmune Disease Therapeutics in Global, including the following market information:
Global Autoimmune Disease Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Autoimmune Disease Therapeutics market was valued at 101010 million in 2021 and is projected to reach US$ 118410 million by 2028, at a CAGR of 2.3% during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
Immunosuppressants Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Autoimmune Disease Therapeutics include Pfizer, Novartis, Johnson & Johnson Services, Merck, Sanofi, Abott, Bristol-Myers Squibb, Amgen and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Autoimmune Disease Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Autoimmune Disease Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Autoimmune Disease Therapeutics Market Segment Percentages, by Type, 2021 (%)
    Immunosuppressants
    Anti-Inflammatory Drugs
    Corticosteroids
    Nonsteroidal Anti-inflammatory Drugs
    Biologics
    Others
Global Autoimmune Disease Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Autoimmune Disease Therapeutics Market Segment Percentages, by Application, 2021 (%)
    Hospitals
    Clinics
    Independent Pharmacies
    Others
Global Autoimmune Disease Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Autoimmune Disease Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autoimmune Disease Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Autoimmune Disease Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Pfizer
    Novartis
    Johnson & Johnson Services
    Merck
    Sanofi
    Abott
    Bristol-Myers Squibb
    Amgen
    Bayer
    F. Hoffmann-La Roche
    Eli Lilly and Company
1 Introduction to Research & Analysis Reports
    1.1 Autoimmune Disease Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Autoimmune Disease Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Autoimmune Disease Therapeutics Overall Market Size
    2.1 Global Autoimmune Disease Therapeutics Market Size: 2021 VS 2028
    2.2 Global Autoimmune Disease Therapeutics Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Autoimmune Disease Therapeutics Players in Global Market
    3.2 Top Global Autoimmune Disease Therapeutics Companies Ranked by Revenue
    3.3 Global Autoimmune Disease Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 Autoimmune Disease Therapeutics Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Autoimmune Disease Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Autoimmune Disease Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 Autoimmune Disease Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Autoimmune Disease Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Autoimmune Disease Therapeutics Market Size Markets, 2021 & 2028
        4.1.2 Immunosuppressants
        4.1.3 Anti-Inflammatory Drugs
        4.1.4 Corticosteroids
        4.1.5 Nonsteroidal Anti-inflammatory Drugs
        4.1.6 Biologics
        4.1.7 Others
    4.2 By Type - Global Autoimmune Disease Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global Autoimmune Disease Therapeutics Revenue, 2017-2022
        4.2.2 By Type - Global Autoimmune Disease Therapeutics Revenue, 2023-2028
        4.2.3 By Type - Global Autoimmune Disease Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Autoimmune Disease Therapeutics Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Independent Pharmacies
        5.1.5 Others
    5.2 By Application - Global Autoimmune Disease Therapeutics Revenue & Forecasts
        5.2.1 By Application - Global Autoimmune Disease Therapeutics Revenue, 2017-2022
        5.2.2 By Application - Global Autoimmune Disease Therapeutics Revenue, 2023-2028
        5.2.3 By Application - Global Autoimmune Disease Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Autoimmune Disease Therapeutics Market Size, 2021 & 2028
    6.2 By Region - Global Autoimmune Disease Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global Autoimmune Disease Therapeutics Revenue, 2017-2022
        6.2.2 By Region - Global Autoimmune Disease Therapeutics Revenue, 2023-2028
        6.2.3 By Region - Global Autoimmune Disease Therapeutics Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Autoimmune Disease Therapeutics Revenue, 2017-2028
        6.3.2 US Autoimmune Disease Therapeutics Market Size, 2017-2028
        6.3.3 Canada Autoimmune Disease Therapeutics Market Size, 2017-2028
        6.3.4 Mexico Autoimmune Disease Therapeutics Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Autoimmune Disease Therapeutics Revenue, 2017-2028
        6.4.2 Germany Autoimmune Disease Therapeutics Market Size, 2017-2028
        6.4.3 France Autoimmune Disease Therapeutics Market Size, 2017-2028
        6.4.4 U.K. Autoimmune Disease Therapeutics Market Size, 2017-2028
        6.4.5 Italy Autoimmune Disease Therapeutics Market Size, 2017-2028
        6.4.6 Russia Autoimmune Disease Therapeutics Market Size, 2017-2028
        6.4.7 Nordic Countries Autoimmune Disease Therapeutics Market Size, 2017-2028
        6.4.8 Benelux Autoimmune Disease Therapeutics Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Autoimmune Disease Therapeutics Revenue, 2017-2028
        6.5.2 China Autoimmune Disease Therapeutics Market Size, 2017-2028
        6.5.3 Japan Autoimmune Disease Therapeutics Market Size, 2017-2028
        6.5.4 South Korea Autoimmune Disease Therapeutics Market Size, 2017-2028
        6.5.5 Southeast Asia Autoimmune Disease Therapeutics Market Size, 2017-2028
        6.5.6 India Autoimmune Disease Therapeutics Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Autoimmune Disease Therapeutics Revenue, 2017-2028
        6.6.2 Brazil Autoimmune Disease Therapeutics Market Size, 2017-2028
        6.6.3 Argentina Autoimmune Disease Therapeutics Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Autoimmune Disease Therapeutics Revenue, 2017-2028
        6.7.2 Turkey Autoimmune Disease Therapeutics Market Size, 2017-2028
        6.7.3 Israel Autoimmune Disease Therapeutics Market Size, 2017-2028
        6.7.4 Saudi Arabia Autoimmune Disease Therapeutics Market Size, 2017-2028
        6.7.5 UAE Autoimmune Disease Therapeutics Market Size, 2017-2028
7 Players Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporate Summary
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Autoimmune Disease Therapeutics Major Product Offerings
        7.1.4 Pfizer Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
        7.1.5 Pfizer Key News
    7.2 Novartis
        7.2.1 Novartis Corporate Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Autoimmune Disease Therapeutics Major Product Offerings
        7.2.4 Novartis Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
        7.2.5 Novartis Key News
    7.3 Johnson & Johnson Services
        7.3.1 Johnson & Johnson Services Corporate Summary
        7.3.2 Johnson & Johnson Services Business Overview
        7.3.3 Johnson & Johnson Services Autoimmune Disease Therapeutics Major Product Offerings
        7.3.4 Johnson & Johnson Services Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
        7.3.5 Johnson & Johnson Services Key News
    7.4 Merck
        7.4.1 Merck Corporate Summary
        7.4.2 Merck Business Overview
        7.4.3 Merck Autoimmune Disease Therapeutics Major Product Offerings
        7.4.4 Merck Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
        7.4.5 Merck Key News
    7.5 Sanofi
        7.5.1 Sanofi Corporate Summary
        7.5.2 Sanofi Business Overview
        7.5.3 Sanofi Autoimmune Disease Therapeutics Major Product Offerings
        7.5.4 Sanofi Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
        7.5.5 Sanofi Key News
    7.6 Abott
        7.6.1 Abott Corporate Summary
        7.6.2 Abott Business Overview
        7.6.3 Abott Autoimmune Disease Therapeutics Major Product Offerings
        7.6.4 Abott Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
        7.6.5 Abott Key News
    7.7 Bristol-Myers Squibb
        7.7.1 Bristol-Myers Squibb Corporate Summary
        7.7.2 Bristol-Myers Squibb Business Overview
        7.7.3 Bristol-Myers Squibb Autoimmune Disease Therapeutics Major Product Offerings
        7.7.4 Bristol-Myers Squibb Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
        7.7.5 Bristol-Myers Squibb Key News
    7.8 Amgen
        7.8.1 Amgen Corporate Summary
        7.8.2 Amgen Business Overview
        7.8.3 Amgen Autoimmune Disease Therapeutics Major Product Offerings
        7.8.4 Amgen Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
        7.8.5 Amgen Key News
    7.9 Bayer
        7.9.1 Bayer Corporate Summary
        7.9.2 Bayer Business Overview
        7.9.3 Bayer Autoimmune Disease Therapeutics Major Product Offerings
        7.9.4 Bayer Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
        7.9.5 Bayer Key News
    7.10 F. Hoffmann-La Roche
        7.10.1 F. Hoffmann-La Roche Corporate Summary
        7.10.2 F. Hoffmann-La Roche Business Overview
        7.10.3 F. Hoffmann-La Roche Autoimmune Disease Therapeutics Major Product Offerings
        7.10.4 F. Hoffmann-La Roche Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
        7.10.5 F. Hoffmann-La Roche Key News
    7.11 Eli Lilly and Company
        7.11.1 Eli Lilly and Company Corporate Summary
        7.11.2 Eli Lilly and Company Business Overview
        7.11.3 Eli Lilly and Company Autoimmune Disease Therapeutics Major Product Offerings
        7.11.4 Eli Lilly and Company Autoimmune Disease Therapeutics Revenue in Global Market (2017-2022)
        7.11.5 Eli Lilly and Company Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com